Two-year results of multicenter phase III trials on the effect of the addition of sirolimus to Cyclosporine-based immunosuppressive regimens in renal transplantation
Author:
- 1 May 2003
- journal article
- clinical trial
- Published by Elsevier in Transplantation Proceedings
- Vol. 35 (3) , S37-S51
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Median effect analysis of efficacy versus adverse effects of immunosuppressantsClinical Pharmacology & Therapeutics, 2001
- A WORLDWIDE, PHASE III, RANDOMIZED, CONTROLLED, SAFETY AND EFFICACY STUDY OF A SIROLIMUS/CYCLOSPORINE REGIMEN FOR PREVENTION OF ACUTE REJECTION IN RECIPIENTS OF PRIMARY MISMATCHED RENAL ALLOGRAFTSTransplantation, 2001
- Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre studyThe Lancet, 2000
- Metabolism of cyclosporine by cytochromes P450 3A9 and 3A4European Journal of Drug Metabolism and Pharmacokinetics, 1999
- P‐glycoprotein and Drug Therapy in Organ TransplantationThe Journal of Clinical Pharmacology, 1999
- A BLINDED, LONG-TERM, RANDOMIZED MULTICENTER STUDY OF MYCOPHENOLATE MOFETIL IN CADAVERIC RENAL TRANSPLANTATIONTransplantation, 1998
- Relative Tissue Distributions of Cyclosporine and Sirolimus After Concomitant Peroral Administration to the Rat: Evidence for Pharmacokinetic InteractionsTherapeutic Drug Monitoring, 1998
- The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent*Clinical Pharmacology & Therapeutics, 1998
- Inferior outcome of two-haplotype matched renal transplants in blacks: Role of early rejectionKidney International, 1995
- CyclosporineNew England Journal of Medicine, 1989